Drug · DIN 02400502
DIVALPROEX
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 31, 2017; first marketed February 13, 2013.
- Drug Identification Number (DIN)
- 02400502
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Enteric-Coated)
- Route
- Oral
- Therapeutic class (ATC)
- Valproic acid N03AG01
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VALPROIC ACID (DIVALPROEX SODIUM) | 250 MG | ECT |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 11, 2013: NOC 14077Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named DIVALPROEX
- DIN 02239517 · Approved
- DIN 02239518 · Approved
- DIN 02239519 · Approved
- DIN 02400499 · Dormant
- DIN 02400510 · Dormant